Salute e Benessere
EQT Life Sciences leads Series A funding round for maternal health company Nua Surgical
Barry McCann , CEO of Nua Surgical, commented, "Securing this Series A financing is a crucial milestone for Nua Surgical. It not only provides the capital needed to advance our product but also brings on board a group of experienced investors who share our vision for transforming maternal health. We are eager to leverage their expertise as we move towards commercializing SteriCISION."
"Nua Surgical's SteriCISION C-Section Retractor has the potential to significantly enhance outcomes for mothers undergoing C-section procedures," said Anne Portwich, Partner at EQT. "We are excited to support the company's journey towards market entry. This innovative device has the potential to improve the quality of care and reduce healthcare costs, making it a perfect fit for our EQT Health Economics strategy."
With the closure of this round, Anne Portwich, Partner at EQT, and Anula Jayasuriya , Co-Founder of Kidron Capital, will join the Nua Surgical Board of Directors, while Gabrielle Guttman of TMC Venture Fund and Prashanthi Ramesh of EQT will serve as Board Observers.
EQT Press Office, press@eqtpartners.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/eqt-life-sciences-leads-series-a-funding-round-for-maternal-health-company-nua-surgical,c4076882
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/eqt-life-sciences-leads-series-a-funding-round-for-maternal-health-company-nua-surgical-302324810.html